Patent: 9,915,643
✉ Email this page to a colleague
Summary for Patent: 9,915,643
Title: | Spatial orientation determination in portable clinical analysis systems |
Abstract: | The present invention covers the integration and utility of accelerometer features into a clinical analysis system. For example, measurement of dynamic acceleration and orientation of a blood-testing instrument with respect to Earth\'s gravitational field may be used to determine reliability of a test procedure and optionally to provide corrective elements thereof. |
Inventor(s): | Vandersleen; Gary (Plainsboro, NJ), Emeric; Pierre (Princeton, NJ), Wasserman; Paul (Oakhurst, NJ), Soman; Narendra (Hillsborough, NJ), Davis; Graham (Princeton, NJ) |
Assignee: | Abbott Point of Care Inc. (Princeton, NJ) |
Application Number: | 15/291,454 |
Patent Claims: | see list of patent claims |
Details for Patent 9,915,643
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Ferring Pharmaceuticals Inc. | NOVAREL | chorionic gonadotropin | For Injection | 017016 | 01/15/1974 | ⤷ Try a Trial | 2032-12-17 |
Ferring Pharmaceuticals Inc. | NOVAREL | chorionic gonadotropin | For Injection | 017016 | 12/27/1984 | ⤷ Try a Trial | 2032-12-17 |
Ferring Pharmaceuticals Inc. | NOVAREL | chorionic gonadotropin | For Injection | 017016 | 02/15/1985 | ⤷ Try a Trial | 2032-12-17 |
Ferring Pharmaceuticals Inc. | NOVAREL | chorionic gonadotropin | For Injection | 017016 | 02/16/1990 | ⤷ Try a Trial | 2032-12-17 |
Bel-mar Laboratories, Inc. | CHORIONIC GONADOTROPIN | chorionic gonadotropin | Injection | 017054 | 03/26/1974 | ⤷ Try a Trial | 2032-12-17 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |